LNAI
Lunai Bioworks Inc.
NASDAQ: LNAI · HEALTHCARE · BIOTECHNOLOGY
$0.33
-0.81% today
Updated 2026-04-30
Market cap
$11.19M
P/E ratio
—
P/S ratio
70,327.55x
EPS (TTM)
$-7.56
Dividend yield
—
52W range
$0 – $4
Volume
24.1M
Lunai Bioworks Inc. (LNAI) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $-20.61M | $-15.73M | $-11.77M | $-10.97M | $-7.87M |
| Capital expenditures | $48887.00 | $5156.00 | $29774.00 | $70430.00 | $3.00 |
| Depreciation | $391416.00 | $123590.00 | $113496.00 | $121859.00 | $129095.00 |
| Stock-based comp | — | $5.49M | $3.54M | $4.67M | $3.31M |
| Free cash flow | $-20.66M | $-15.74M | $-11.80M | $-11.04M | $-7.87M |
| Investing cash flow | $-48892.00 | $-5156.00 | $-29774.00 | $-1.26M | $-500000.00 |
| Financing cash flow | $32.60M | $4.25M | $4.52M | $10.52M | $8.38M |
| Dividends paid | — | — | — | — | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |